Exact Mass: 739.406

Exact Mass Matches: 739.406

Found 132 metabolites which its exact mass value is equals to given mass value 739.406, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

CE-108

(1R,3S,9R,10S,13R,15E,17E,19E,21E,23R,25S,26R,27S)-23-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-10-ethyl-1,3,9,27-tetrahydroxy-13-methyl-7,11-dioxo-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraene-26-carboxylic acid

C37H57NO14 (739.3779)


   

Lycoperoside D

2-{[4,5-dihydroxy-2-(hydroxymethyl)-6-{5,7,9,13-tetramethyl-5-oxaspiro[pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane-6,2-piperidine]oxy}oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C39H65NO12 (739.4507)


Alkaloid from Lycopersicon esculentum (tomato). Lycoperoside D is found in garden tomato and garden tomato (variety). Lycoperoside D is found in garden tomato. Lycoperoside D is an alkaloid from Lycopersicon esculentum (tomato

   

PE(14:1(9Z)/PGJ2)

(2-aminoethoxy)[(2R)-2-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}-3-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphinic acid

C39H66NO10P (739.4424)


PE(14:1(9Z)/PGJ2) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(14:1(9Z)/PGJ2), in particular, consists of one chain of one 9Z-tetradecenoyl at the C-1 position and one chain of Prostaglandin J2 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

PE(PGJ2/14:1(9Z))

(2-aminoethoxy)[(2R)-3-{[(5Z)-7-[(1S,5R)-5-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-4-oxocyclopent-2-en-1-yl]hept-5-enoyl]oxy}-2-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphinic acid

C39H66NO10P (739.4424)


PE(PGJ2/14:1(9Z)) is an oxidized phosphatidylethanolamine (PE). Oxidized phosphatidylethanolamines are glycerophospholipids in which a phosphorylethanolamine moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylethanolamines belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylethanolamines can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PE(PGJ2/14:1(9Z)), in particular, consists of one chain of one Prostaglandin J2 at the C-1 position and one chain of 9Z-tetradecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PEs can be synthesized via three different routes. In one route, the oxidized PE is synthetized de novo following the same mechanisms as for PEs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PE backbone, mainly through the action of LOX (PMID: 33329396).

   

Annomuricatin B

2-[1,4,7,10,13,16-Hexahydroxy-18-(1-hydroxyethyl)-9-[(1H-indol-3-yl)methyl]-6-methyl-12-(2-methylpropyl)-19-oxo-3H,6H,9H,12H,15H,18H,19H,21H,22H,23H,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-3-yl]ethanimidate

C35H49N9O9 (739.3653)


Constituent of the seeds of Annona muricata (soursop). Annomuricatin B is found in fruits.

   
   

Annomuricatin B

Annomuricatin B

C35H49N9O9 (739.3653)


   

Cyclomontanin A

Cyclomontanin A

C35H49N9O9 (739.3653)


A homodetic cyclic peptide composed of L-alanyl, L-tryptophyl, L-threonyl, L-prolylglycyl, L-leucyl and L-asparaginyl residues linked in a sequence. It is isolated from the seeds of Annona montana and has been shown to exhibit anti-inflammatory activity.

   

(2S,3R,4R,5R,6S)-2-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-{5,7,9,13-tetramethyl-5-oxaspiro[pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane-6,2-piperidine]-3-oloxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

(2S,3R,4R,5R,6S)-2-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-{5,7,9,13-tetramethyl-5-oxaspiro[pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane-6,2-piperidine]-3-oloxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol

C39H65NO12 (739.4507)


   

cyclo(-Gly-transPro-Thr-Trp-Ala-Asn-Leu-)|cyclomontanin A

cyclo(-Gly-transPro-Thr-Trp-Ala-Asn-Leu-)|cyclomontanin A

C35H49N9O9 (739.3653)


   
   

C39H65NO12_15-Hydroxyspirosolan-3-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside

NCGC00347420-02_C39H65NO12_15-Hydroxyspirosolan-3-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside

C39H65NO12 (739.4507)


   

PS(13:0/20:5(5Z,8Z,11Z,14Z,17Z))

1-tridecanoyl-2-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-glycero-3-phosphoserine

C39H66NO10P (739.4424)


   

PS(15:1(9Z)/18:4(6Z,9Z,12Z,15Z))

1-(9Z-pentadecenoyl)-2-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-glycero-3-phosphoserine

C39H66NO10P (739.4424)


   

PS(18:4(6Z,9Z,12Z,15Z)/15:1(9Z))

1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-2-(9Z-pentadecenoyl)-glycero-3-phosphoserine

C39H66NO10P (739.4424)


   

PS(20:5(5Z,8Z,11Z,14Z,17Z)/13:0)

1-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-2-tridecanoyl-glycero-3-phosphoserine

C39H66NO10P (739.4424)


   

g-Tomatine

2-{[4,5-dihydroxy-2-(hydroxymethyl)-6-{5,7,9,13-tetramethyl-5-oxaspiro[pentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosane-6,2-piperidine]oxy}oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C39H65NO12 (739.4507)


   

PS 33:5

1-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-2-(9Z-pentadecenoyl)-glycero-3-phosphoserine

C39H66NO10P (739.4424)


   

Thymopentin Acetate (TP-5)

Thymopentin Acetate (TP-5)

C32H53N9O11 (739.3864)


   

Difelikefalin acetate

Difelikefalin acetate

C38H57N7O8 (739.4268)


   
   

cyclo[DL-Ala-DL-Trp-DL-Leu-Gly-DL-xiThr-DL-Pro-DL-Asn]

cyclo[DL-Ala-DL-Trp-DL-Leu-Gly-DL-xiThr-DL-Pro-DL-Asn]

C35H49N9O9 (739.3653)


   

PE(14:1(9Z)/PGJ2)

PE(14:1(9Z)/PGJ2)

C39H66NO10P (739.4424)


   

PE(PGJ2/14:1(9Z))

PE(PGJ2/14:1(9Z))

C39H66NO10P (739.4424)


   

(1R,3S,9R,10S,13R,15E,17E,19E,21E,23R,25S,26R,27S)-23-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-10-ethyl-1,3,9,27-tetrahydroxy-13-methyl-7,11-dioxo-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraene-26-carboxylic acid

(1R,3S,9R,10S,13R,15E,17E,19E,21E,23R,25S,26R,27S)-23-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-10-ethyl-1,3,9,27-tetrahydroxy-13-methyl-7,11-dioxo-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraene-26-carboxylic acid

C37H57NO14 (739.3779)


   

SHexCer 30:1;3O

SHexCer 30:1;3O

C36H69NO12S (739.454)


   

Hex2Cer 26:6;2O

Hex2Cer 26:6;2O

C38H61NO13 (739.4143)


   
   
   
   
   

SHexCer 12:1;2O/18:0;O

SHexCer 12:1;2O/18:0;O

C36H69NO12S (739.454)


   

SHexCer 12:0;2O/18:1;O

SHexCer 12:0;2O/18:1;O

C36H69NO12S (739.454)


   

SHexCer 16:0;2O/14:1;O

SHexCer 16:0;2O/14:1;O

C36H69NO12S (739.454)


   

SHexCer 13:1;2O/17:0;O

SHexCer 13:1;2O/17:0;O

C36H69NO12S (739.454)


   

SHexCer 10:0;2O/20:1;O

SHexCer 10:0;2O/20:1;O

C36H69NO12S (739.454)


   

SHexCer 18:1;2O/12:0;O

SHexCer 18:1;2O/12:0;O

C36H69NO12S (739.454)


   

SHexCer 16:1;2O/14:0;O

SHexCer 16:1;2O/14:0;O

C36H69NO12S (739.454)


   

SHexCer 10:1;2O/20:0;O

SHexCer 10:1;2O/20:0;O

C36H69NO12S (739.454)


   

SHexCer 11:0;2O/19:1;O

SHexCer 11:0;2O/19:1;O

C36H69NO12S (739.454)


   

SHexCer 15:0;2O/15:1;O

SHexCer 15:0;2O/15:1;O

C36H69NO12S (739.454)


   

SHexCer 17:0;2O/13:1;O

SHexCer 17:0;2O/13:1;O

C36H69NO12S (739.454)


   

SHexCer 15:1;2O/15:0;O

SHexCer 15:1;2O/15:0;O

C36H69NO12S (739.454)


   

SHexCer 17:1;2O/13:0;O

SHexCer 17:1;2O/13:0;O

C36H69NO12S (739.454)


   

SHexCer 11:1;2O/19:0;O

SHexCer 11:1;2O/19:0;O

C36H69NO12S (739.454)


   

SHexCer 18:0;2O/12:1;O

SHexCer 18:0;2O/12:1;O

C36H69NO12S (739.454)


   

SHexCer 14:0;2O/16:1;O

SHexCer 14:0;2O/16:1;O

C36H69NO12S (739.454)


   

SHexCer 14:1;2O/16:0;O

SHexCer 14:1;2O/16:0;O

C36H69NO12S (739.454)


   

Lnaps 11:0/N-22:5

Lnaps 11:0/N-22:5

C39H66NO10P (739.4424)


   

Lnaps 22:5/N-11:0

Lnaps 22:5/N-11:0

C39H66NO10P (739.4424)


   

Lnaps 20:5/N-13:0

Lnaps 20:5/N-13:0

C39H66NO10P (739.4424)


   

Lnaps 18:4/N-15:1

Lnaps 18:4/N-15:1

C39H66NO10P (739.4424)


   

Lnaps 13:1/N-20:4

Lnaps 13:1/N-20:4

C39H66NO10P (739.4424)


   

Lnaps 20:4/N-13:1

Lnaps 20:4/N-13:1

C39H66NO10P (739.4424)


   

Lnaps 15:1/N-18:4

Lnaps 15:1/N-18:4

C39H66NO10P (739.4424)


   

Lnaps 16:3/N-17:2

Lnaps 16:3/N-17:2

C39H66NO10P (739.4424)


   

Lnaps 13:0/N-20:5

Lnaps 13:0/N-20:5

C39H66NO10P (739.4424)


   

Lnaps 17:2/N-16:3

Lnaps 17:2/N-16:3

C39H66NO10P (739.4424)


   

2-amino-3-[[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C39H66NO10P (739.4424)


   

2-amino-3-[[3-[(Z)-heptadec-9-enoyl]oxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-[(Z)-heptadec-9-enoyl]oxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C39H66NO10P (739.4424)


   

2-amino-3-[hydroxy-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-tridecanoyloxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-tridecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C39H66NO10P (739.4424)


   

2-amino-3-[hydroxy-[2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxy-3-pentadecanoyloxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxy-3-pentadecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C39H66NO10P (739.4424)


   

2-amino-3-[hydroxy-[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C39H66NO10P (739.4424)


   

2-amino-3-[hydroxy-[2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C39H66NO10P (739.4424)


   

2-amino-3-[[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-undecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-undecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C39H66NO10P (739.4424)


   

(2S)-2-amino-3-[hydroxy-[(2R)-3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxy-2-[(E)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

(2S)-2-amino-3-[hydroxy-[(2R)-3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxy-2-[(E)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C39H66NO10P (739.4424)


   

(2S)-2-amino-3-[[3-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[3-[(11E,14E)-heptadeca-11,14-dienoyl]oxy-2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C39H66NO10P (739.4424)


   

(2R)-2-amino-3-[[(2S)-3-[(4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoyl]oxy-2-undecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2R)-2-amino-3-[[(2S)-3-[(4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoyl]oxy-2-undecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C39H66NO10P (739.4424)


   

(2S)-2-amino-3-[hydroxy-[(2R)-2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxy-3-[(E)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

(2S)-2-amino-3-[hydroxy-[(2R)-2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxy-3-[(E)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C39H66NO10P (739.4424)


   

(2S)-2-amino-3-[[3-heptadecanoyloxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[3-heptadecanoyloxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C39H66NO10P (739.4424)


   

(2S)-2-amino-3-[hydroxy-[(2S)-2-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-tridecanoyloxypropoxy]phosphoryl]oxypropanoic acid

(2S)-2-amino-3-[hydroxy-[(2S)-2-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-tridecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C39H66NO10P (739.4424)


   

(2S)-2-amino-3-[hydroxy-[(2R)-3-[(6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoyl]oxy-2-[(E)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

(2S)-2-amino-3-[hydroxy-[(2R)-3-[(6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoyl]oxy-2-[(E)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C39H66NO10P (739.4424)


   

(2S)-2-amino-3-[[(2S)-2-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-undecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[(2S)-2-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-undecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C39H66NO10P (739.4424)


   

(2R)-2-amino-3-[hydroxy-[(2S)-3-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxy-2-tridecanoyloxypropoxy]phosphoryl]oxypropanoic acid

(2R)-2-amino-3-[hydroxy-[(2S)-3-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxy-2-tridecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C39H66NO10P (739.4424)


   

(2S)-2-amino-3-[[(2S)-2-[(4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoyl]oxy-3-undecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[(2S)-2-[(4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoyl]oxy-3-undecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C39H66NO10P (739.4424)


   

(2S)-2-amino-3-[[3-[(E)-heptadec-7-enoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[3-[(E)-heptadec-7-enoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C39H66NO10P (739.4424)


   

(2S)-2-amino-3-[hydroxy-[(2R)-2-[(6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoyl]oxy-3-[(E)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

(2S)-2-amino-3-[hydroxy-[(2R)-2-[(6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoyl]oxy-3-[(E)-pentadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C39H66NO10P (739.4424)


   

(2R)-2-amino-3-[[(2S)-3-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-undecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2R)-2-amino-3-[[(2S)-3-[(7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-undecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C39H66NO10P (739.4424)


   

(2S)-2-amino-3-[[3-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[3-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C39H66NO10P (739.4424)


   
   
   

PC 18:4/12:3;O3

PC 18:4/12:3;O3

C38H62NO11P (739.406)


   
   
   
   
   
   
   
   
   

PE 22:4/11:3;O3

PE 22:4/11:3;O3

C38H62NO11P (739.406)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Hex2Cer 26:6;O2

Hex2Cer 26:6;O2

C38H61NO13 (739.4143)


   

SHexCer 30:1;O3

SHexCer 30:1;O3

C36H69NO12S (739.454)


   
   

Thymopentin (acetate)

Thymopentin (acetate)

C32H53N9O11 (739.3864)


Thymopentin acetate is a biologically active peptide secreted mainly by the epithelial cells of thymic cortex and medulla. Thymopentin acetate is an effective immunomodulatory agent with a short plasma half-life of 30 seconds. Thymopentin acetate enhances the generation of T-cell lineage derived from human embryonic stem cells (hESCs)[1][2]. Thymopentin acetate is a biologically active peptide secreted mainly by the epithelial cells of thymic cortex and medulla. Thymopentin acetate is an effective immunomodulatory agent with a short plasma half-life of 30 seconds. Thymopentin acetate enhances the generation of T-cell lineage derived from human embryonic stem cells (hESCs)[1][2]. Thymopentin acetate is a biologically active peptide secreted mainly by the epithelial cells of thymic cortex and medulla. Thymopentin acetate is an effective immunomodulatory agent with a short plasma half-life of 30 seconds. Thymopentin acetate enhances the generation of T-cell lineage derived from human embryonic stem cells (hESCs)[1][2].

   

(1r,13r,15e,17e,19e,21e,23r,25s,26r,27s)-23-[(4-amino-3,5-dihydroxy-6-methyloxan-2-yl)oxy]-10-ethyl-1,3,9,27-tetrahydroxy-13-methyl-7,11-dioxo-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraene-26-carboxylic acid

(1r,13r,15e,17e,19e,21e,23r,25s,26r,27s)-23-[(4-amino-3,5-dihydroxy-6-methyloxan-2-yl)oxy]-10-ethyl-1,3,9,27-tetrahydroxy-13-methyl-7,11-dioxo-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraene-26-carboxylic acid

C37H57NO14 (739.3779)


   

(2r,3r,4s,5s,6r)-2-{[(4r,5r)-13-(4-hydroxy-5,6-dimethoxy-3-methylpyridin-2-yl)-3,5,7,11-tetramethyltrideca-2,6,8,11-tetraen-4-yl]oxy}-6-({[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(4r,5r)-13-(4-hydroxy-5,6-dimethoxy-3-methylpyridin-2-yl)-3,5,7,11-tetramethyltrideca-2,6,8,11-tetraen-4-yl]oxy}-6-({[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C37H57NO14 (739.3779)


   

(2r)-2-{[(1s)-1-{[2-(4-{[(2s,3r,4s,5r,6r)-3,4-dihydroxy-5-[(1-hydroxyethylidene)amino]-6-methyloxan-2-yl]oxy}phenyl)ethenyl]-c-hydroxycarbonimidoyl}-2-(1-methylindol-3-yl)ethyl]amino}-4-methyl-n-(2-phenylethyl)pentanimidic acid

(2r)-2-{[(1s)-1-{[2-(4-{[(2s,3r,4s,5r,6r)-3,4-dihydroxy-5-[(1-hydroxyethylidene)amino]-6-methyloxan-2-yl]oxy}phenyl)ethenyl]-c-hydroxycarbonimidoyl}-2-(1-methylindol-3-yl)ethyl]amino}-4-methyl-n-(2-phenylethyl)pentanimidic acid

C42H53N5O7 (739.3945)


   

2-{[4,5-dihydroxy-2-(hydroxymethyl)-6-{5',7,9,13-tetramethyl-5-oxaspiro[pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane-6,2'-piperidine]oxy}oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[4,5-dihydroxy-2-(hydroxymethyl)-6-{5',7,9,13-tetramethyl-5-oxaspiro[pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane-6,2'-piperidine]oxy}oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C39H65NO12 (739.4507)


   

[(1r,2r,3r,4s,5s,7r,9s,10r,11s,13s,15r)-9,15-bis(acetyloxy)-7-hydroxy-5,9,12,12-tetramethyl-2-{[(2e)-2-methylbut-2-enoyl]oxy}-4-[(3-methylbutanoyl)oxy]-8-oxotetracyclo[8.5.0.0³,⁷.0¹¹,¹³]pentadecan-1-yl]methyl pyridine-3-carboxylate

[(1r,2r,3r,4s,5s,7r,9s,10r,11s,13s,15r)-9,15-bis(acetyloxy)-7-hydroxy-5,9,12,12-tetramethyl-2-{[(2e)-2-methylbut-2-enoyl]oxy}-4-[(3-methylbutanoyl)oxy]-8-oxotetracyclo[8.5.0.0³,⁷.0¹¹,¹³]pentadecan-1-yl]methyl pyridine-3-carboxylate

C40H53NO12 (739.3568)


   

2-[(6s,9s,12s,15s,18r,23as)-6-[(2s)-butan-2-yl]-1,4,7,10,13,16-hexahydroxy-18-[(1r)-1-hydroxyethyl]-15-(1h-indol-3-ylmethyl)-12-methyl-19-oxo-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-9-yl]ethanimidic acid

2-[(6s,9s,12s,15s,18r,23as)-6-[(2s)-butan-2-yl]-1,4,7,10,13,16-hexahydroxy-18-[(1r)-1-hydroxyethyl]-15-(1h-indol-3-ylmethyl)-12-methyl-19-oxo-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-9-yl]ethanimidic acid

C35H49N9O9 (739.3653)


   

2-{[2-({[1-(2-{[1,2-dihydroxy-3-(methylamino)decylidene]amino}-3-methylbutanoyl)pyrrolidin-2-yl](hydroxy)methylidene}amino)-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

2-{[2-({[1-(2-{[1,2-dihydroxy-3-(methylamino)decylidene]amino}-3-methylbutanoyl)pyrrolidin-2-yl](hydroxy)methylidene}amino)-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-(4-hydroxyphenyl)propanoic acid

C39H57N5O9 (739.4156)


   

2-{[13-(4-hydroxy-5,6-dimethoxy-3-methylpyridin-2-yl)-3,5,7,11-tetramethyltrideca-2,6,8,11-tetraen-4-yl]oxy}-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

2-{[13-(4-hydroxy-5,6-dimethoxy-3-methylpyridin-2-yl)-3,5,7,11-tetramethyltrideca-2,6,8,11-tetraen-4-yl]oxy}-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C37H57NO14 (739.3779)


   

2-[(2s,5r,8s,11s,14r,17s)-5-(3-aminopropyl)-3,6,9,12,15,18-hexahydroxy-8-(1h-indol-3-ylmethyl)-17-isopropyl-11,14-bis(2-methylpropyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]ethanimidic acid

2-[(2s,5r,8s,11s,14r,17s)-5-(3-aminopropyl)-3,6,9,12,15,18-hexahydroxy-8-(1h-indol-3-ylmethyl)-17-isopropyl-11,14-bis(2-methylpropyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]ethanimidic acid

C37H57N9O7 (739.4381)


   

2-[5-(3-aminopropyl)-3,6,9,12,15,18-hexahydroxy-8-(1h-indol-3-ylmethyl)-17-isopropyl-11,14-bis(2-methylpropyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]ethanimidic acid

2-[5-(3-aminopropyl)-3,6,9,12,15,18-hexahydroxy-8-(1h-indol-3-ylmethyl)-17-isopropyl-11,14-bis(2-methylpropyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]ethanimidic acid

C37H57N9O7 (739.4381)


   

2-(1-{1-[2-({2-[(3-amino-1,2-dihydroxydecylidene)amino]-1-hydroxy-3-methylbutylidene}amino)-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl}-n-methylformamido)-3-(4-hydroxyphenyl)propanoic acid

2-(1-{1-[2-({2-[(3-amino-1,2-dihydroxydecylidene)amino]-1-hydroxy-3-methylbutylidene}amino)-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl}-n-methylformamido)-3-(4-hydroxyphenyl)propanoic acid

C39H57N5O9 (739.4156)


   

[9,15-bis(acetyloxy)-7-hydroxy-5,9,12,12-tetramethyl-2-[(2-methylbut-2-enoyl)oxy]-4-[(3-methylbutanoyl)oxy]-8-oxotetracyclo[8.5.0.0³,⁷.0¹¹,¹³]pentadecan-1-yl]methyl pyridine-3-carboxylate

[9,15-bis(acetyloxy)-7-hydroxy-5,9,12,12-tetramethyl-2-[(2-methylbut-2-enoyl)oxy]-4-[(3-methylbutanoyl)oxy]-8-oxotetracyclo[8.5.0.0³,⁷.0¹¹,¹³]pentadecan-1-yl]methyl pyridine-3-carboxylate

C40H53NO12 (739.3568)


   

2-[(3s,6s,9s,12s,18s,23as)-1,4,7,10,13,16-hexahydroxy-18-[(1r)-1-hydroxyethyl]-9-(1h-indol-3-ylmethyl)-6-methyl-12-(2-methylpropyl)-19-oxo-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-3-yl]ethanimidic acid

2-[(3s,6s,9s,12s,18s,23as)-1,4,7,10,13,16-hexahydroxy-18-[(1r)-1-hydroxyethyl]-9-(1h-indol-3-ylmethyl)-6-methyl-12-(2-methylpropyl)-19-oxo-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-3-yl]ethanimidic acid

C35H49N9O9 (739.3653)


   

(1r,3s,9r,10s,13r,15e,17e,19e,21e,23r,25s,26r,27s)-23-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-10-ethyl-1,3,9,27-tetrahydroxy-13-methyl-7,11-dioxo-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraene-26-carboxylic acid

(1r,3s,9r,10s,13r,15e,17e,19e,21e,23r,25s,26r,27s)-23-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-10-ethyl-1,3,9,27-tetrahydroxy-13-methyl-7,11-dioxo-12,29-dioxabicyclo[23.3.1]nonacosa-15,17,19,21-tetraene-26-carboxylic acid

C37H57NO14 (739.3779)


   

2-[(8s,11s,14r)-5-(3-aminopropyl)-3,6,9,12,15,18-hexahydroxy-8-(1h-indol-3-ylmethyl)-17-isopropyl-11,14-bis(2-methylpropyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]ethanimidic acid

2-[(8s,11s,14r)-5-(3-aminopropyl)-3,6,9,12,15,18-hexahydroxy-8-(1h-indol-3-ylmethyl)-17-isopropyl-11,14-bis(2-methylpropyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),3,6,9,12,15-hexaen-2-yl]ethanimidic acid

C37H57N9O7 (739.4381)


   

2-[(3s,6s,9s,12s,18r,23as)-1,4,7,10,13,16-hexahydroxy-18-[(1r)-1-hydroxyethyl]-9-(1h-indol-3-ylmethyl)-6-methyl-12-(2-methylpropyl)-19-oxo-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-3-yl]ethanimidic acid

2-[(3s,6s,9s,12s,18r,23as)-1,4,7,10,13,16-hexahydroxy-18-[(1r)-1-hydroxyethyl]-9-(1h-indol-3-ylmethyl)-6-methyl-12-(2-methylpropyl)-19-oxo-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-3-yl]ethanimidic acid

C35H49N9O9 (739.3653)


   

2-[(6s,9s,12s,15s,18s,23as)-1,4,7,10,13,16-hexahydroxy-18-[(1r)-1-hydroxyethyl]-15-(1h-indol-3-ylmethyl)-12-methyl-6-(2-methylpropyl)-19-oxo-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-9-yl]ethanimidic acid

2-[(6s,9s,12s,15s,18s,23as)-1,4,7,10,13,16-hexahydroxy-18-[(1r)-1-hydroxyethyl]-15-(1h-indol-3-ylmethyl)-12-methyl-6-(2-methylpropyl)-19-oxo-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-9-yl]ethanimidic acid

C35H49N9O9 (739.3653)


   

2-[1,4,7,10,13,16-hexahydroxy-18-(1-hydroxyethyl)-9-(1h-indol-3-ylmethyl)-6-methyl-12-(2-methylpropyl)-19-oxo-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-3-yl]ethanimidic acid

2-[1,4,7,10,13,16-hexahydroxy-18-(1-hydroxyethyl)-9-(1h-indol-3-ylmethyl)-6-methyl-12-(2-methylpropyl)-19-oxo-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-3-yl]ethanimidic acid

C35H49N9O9 (739.3653)


   

(2r,3s)-2-{[(1s)-1-{[2-(4-{[(2s,3r,4s,5r,6r)-3,4-dihydroxy-5-[(1-hydroxyethylidene)amino]-6-methyloxan-2-yl]oxy}phenyl)ethenyl]-c-hydroxycarbonimidoyl}-2-(1-methylindol-3-yl)ethyl]amino}-3-methyl-n-(2-phenylethyl)pentanimidic acid

(2r,3s)-2-{[(1s)-1-{[2-(4-{[(2s,3r,4s,5r,6r)-3,4-dihydroxy-5-[(1-hydroxyethylidene)amino]-6-methyloxan-2-yl]oxy}phenyl)ethenyl]-c-hydroxycarbonimidoyl}-2-(1-methylindol-3-yl)ethyl]amino}-3-methyl-n-(2-phenylethyl)pentanimidic acid

C42H53N5O7 (739.3945)


   

2-[(3s,6s,9s,12s,18s,23as)-1,4,7,10,13,16-hexahydroxy-18-[(1s)-1-hydroxyethyl]-9-(1h-indol-3-ylmethyl)-6-methyl-12-(2-methylpropyl)-19-oxo-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-3-yl]ethanimidic acid

2-[(3s,6s,9s,12s,18s,23as)-1,4,7,10,13,16-hexahydroxy-18-[(1s)-1-hydroxyethyl]-9-(1h-indol-3-ylmethyl)-6-methyl-12-(2-methylpropyl)-19-oxo-3h,6h,9h,12h,15h,18h,21h,22h,23h,23ah-pyrrolo[1,2-a]1,4,7,10,13,16,19-heptaazacyclohenicosan-3-yl]ethanimidic acid

C35H49N9O9 (739.3653)


   

(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(1r,2s,4s,5's,6s,7s,8r,9s,12s,13s,16s,18s)-5',7,9,13-tetramethyl-5-oxaspiro[pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane-6,2'-piperidine]oxy]oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(1r,2s,4s,5's,6s,7s,8r,9s,12s,13s,16s,18s)-5',7,9,13-tetramethyl-5-oxaspiro[pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane-6,2'-piperidine]oxy]oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C39H65NO12 (739.4507)